Alembic PharmaceuticalsAPLLTD 
$14.40-0.71%24h
-0.71%24h
Global rank4122
Market cap$2.83B
Change 7d9.16%
YTD Performance58.95%
SP500 benchmarkOutperform
P/E0.83
P/S4.32
Revenue$655.63M
Earnings$40.77M
Dividend yield-
Main Sector
Healthcare
Alembic Pharmaceuticals APLLTD Total Debt
APLLTD Total Debt in 2022: $8.25M
According to Alembic Pharmaceuticals latest financial reports the total debt is $8.25M, an decrease of -4.03% to 2022. At the end of 2022 company had $8.60M total debt. This figure represents the debts and financial obligations that Alembic Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Alembic Pharmaceuticals APLLTD Total Debt History from 2023 to 2022
-
Value:-
APLLTD Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $8.25M | -4.03% |
| 2022 | $8.60M | -73.42% |
| 2021 | $32.36M | -71.73% |
| 2020 | $114.48M | 92.33% |
| 2019 | $59.52M | - |
View the Top Total Debt Stocks 
